In a filing, Enliven Therapeutics Inc revealed its PRESIDENT AND CEO Kintz Samuel unloaded Company’s shares for reported $0.26 million on Jun 25 ’24. In the deal valued at $21.66 per share,12,000 shares were sold. As a result of this transaction, Kintz Samuel now holds 1,075,525 shares worth roughly $25.14 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Heyman Richard A. sold 1,270 shares, generating $27,278 in total proceeds. Upon selling the shares at $21.48, the Director now owns 134,615 shares.
Before that, Patel Anish sold 1,133 shares. Enliven Therapeutics Inc shares valued at $22,722 were divested by the CHIEF OPERATING OFFICER at a price of $20.06 per share. As a result of the transaction, Patel Anish now holds 0 shares, worth roughly $0.0.
Robert W. Baird initiated its Enliven Therapeutics Inc [ELVN] rating to an Outperform in a research note published on June 11, 2024; the price target was $32. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Jefferies began covering ELVN with “Buy” recommendation on March 29, 2023.
Price Performance Review of ELVN
On Friday, Enliven Therapeutics Inc [NASDAQ:ELVN] saw its stock fall -0.34% to $23.37. Over the last five days, the stock has gained 9.00%. Enliven Therapeutics Inc shares have risen nearly 68.86% since the year began. Nevertheless, the stocks have risen 18.63% over the past one year. While a 52-week high of $26.00 was reached on 04/11/24, a 52-week low of $9.80 was recorded on 03/15/24. SMA at 50 days reached $21.48, while 200 days put it at $16.10. A total of 2.54 million shares were traded, compared to the trading of 0.25 million shares in the previous session.
Levels Of Support And Resistance For ELVN Stock
The 24-hour chart illustrates a support level at 22.83, which if violated will result in even more drops to 22.28. On the upside, there is a resistance level at 24.08. A further resistance level may holdings at 24.78. The Relative Strength Index (RSI) on the 14-day chart is 58.46, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 19.95%. Stochastics%K at 74.37% indicates the stock is a holding.
